Skip to main content

and
  1. Article

    Open Access

    Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients

    CLN2 disease (Neuronal Ceroid Lipofuscinosis Type 2) is an ultra-rare, neurodegenerative lysosomal storage disease, caused by an enzyme deficiency of tripeptidyl peptidase 1 (TPP1). Lack of disease awareness a...

    Sara E. Mole, Angela Schulz, Eben Badoe in Orphanet Journal of Rare Diseases (2021)

  2. Article

    Open Access

    Abnormally increased carotid intima media-thickness and elasticity in patients with Morquio A disease

    Cardiovascular disease frequently causes morbidity and mortality in mucopolysaccharidoses (MPS); however, cardiovascular anatomy and dysfunction in MPS IVA (Morquio A disease) is not well described. Consequent...

    Raymond Y. Wang, Kyle D. Rudser, Donald R. Dengel in Orphanet Journal of Rare Diseases (2020)

  3. Article

    Open Access

    Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis

    Niemann-Pick Disease Type C (NPC) is an inherited, often fatal neurovisceral lysosomal storage disease characterized by cholesterol accumulation in every cell with few known treatments. Defects in cholesterol ...

    Caroline Hastings, Camilo Vieira, Benny Liu in Orphanet Journal of Rare Diseases (2019)